|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Recurrent Neural Tube Defects | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Neural Tube Defects | |||||
| 3 | More general conditions related to this trial | ||||
| Congenital Abnormalities | |||||
| Nervous System Diseases | |||||
| Nervous System Malformations | |||||
| 4 | Interventions listed in this trial | ||||
| Folic Acid and inositol | |||||
| Folic acid and placebo | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Folic Acid | |||||
| Inositol | |||||
| 6 | More general drug interventions related to this trial | ||||
| Growth Substances | |||||
| Hematinics | |||||
| Hematologic Agents | |||||
| Micronutrients | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| Vitamin B Complex | |||||
| Vitamins | |||||
| 7 | Sponsors listed in this trial | ||||
| Institute of Child Health | |||||